Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has reported the conversion of three bonds held by Global Growth Holding Limited, part of its fourth and fifth tranches of a reserved convertible bond with warrants. The conversion at €0.01 per share resulted in the issuance of 3,000,000 new shares to GGHL, which are being directly admitted to trading on the regulated market under the existing prospectus.
Following this transaction, the reserved convertible bond program has been subscribed for a nominal €1.25 million, with €1.02 million of the related capital increase already executed and 23 bonds of the fifth tranche still outstanding. As a result, Fidia’s share capital rises by €30,000 to €10,867,761.90 and its total shares increase to 61,542,927, modestly diluting existing shareholders while further advancing the company’s ongoing capital strengthening plan.
The incremental capital subscribed through the POC structure supports Fidia’s financial flexibility as it continues to invest in its core milling and numerical control technologies. The gradual conversion of the remaining subscribed bonds may continue to alter the company’s capital structure and free float over time, with implications for both ownership concentration and liquidity in the stock.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in numerical control technology and high‑performance integrated milling systems. With over 50 years of experience and about 135 employees, it serves mainly the automotive mould and aerospace sectors, offering solutions that span the entire milling process, from programming to finished product.
The group designs, produces and supports worldwide numerical controls for milling systems, high‑speed milling machines and CAM software for complex shapes. Its positioning as one of the few industrial companies covering the full milling workflow underpins its competitive standing in specialized, high‑precision manufacturing markets.
Average Trading Volume: 1,624,283
Technical Sentiment Signal: Strong Sell
Current Market Cap: €611.8K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.